백신실용화기술개발사업단

Human challenge experiments could accelerate tuberculosis vaccine development. This requires a safe Mycobacterium tuberculosis (Mtb) strain that can both replicate in the host and be reliably cleared. Here we genetically engineered Mtb strains encoding up to three kill switches: two mycobacteriophage lysin operons negatively regulated by tetracycline and a degron domain–NadE fusion, which induces ClpC1-dependent degradation of the essential enzyme NadE, negatively regulated by trimethoprim. The triple-kill-switch (TKS) strain showed similar growth kinetics and antibiotic susceptibilities to wild-type Mtb under permissive conditions but was rapidly killed in vitro without trimethoprim and doxycycline. It established infection in mice receiving antibiotics but was rapidly cleared upon cessation of treatment, and no relapse was observed in infected severe combined immunodeficiency mice or Rag^−/− mice. The TKS strain had an escape mutation rate of less than 10⁻¹⁰ per genome per generation. These findings suggest that the TKS strain could be a safe, effective candidate for a human challenge model.

 

* 본 자료는 상업적 목적 이외에 사용이 가능하며, 출처 표기 및 동의 없이 무단으로 사용할 경우 법적인 제재를 받을 수 있습니다.